SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 135 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $392,000 | -4.9% | 225,400 | 0.0% | 0.15% | -13.5% |
| Q1 2018 | $412,000 | -8.2% | 225,400 | +11.9% | 0.17% | -5.0% |
| Q4 2017 | $449,000 | -2.2% | 201,400 | +27.1% | 0.18% | -8.7% |
| Q3 2017 | $459,000 | -34.9% | 158,400 | 0.0% | 0.20% | -33.3% |
| Q2 2017 | $705,000 | -4.5% | 158,400 | 0.0% | 0.29% | -17.2% |
| Q1 2017 | $738,000 | -23.5% | 158,400 | 0.0% | 0.36% | -27.0% |
| Q4 2016 | $965,000 | +10.5% | 158,400 | 0.0% | 0.49% | +7.8% |
| Q3 2016 | $873,000 | -99.9% | 158,400 | 0.0% | 0.45% | +224.5% |
| Q2 2016 | $601,920,000 | +37.7% | 158,400 | 0.0% | 0.14% | +19.8% |
| Q1 2016 | $437,184,000 | -49.6% | 158,400 | +3.6% | 0.12% | -51.3% |
| Q4 2015 | $866,943,000 | +13.5% | 152,900 | +6.1% | 0.24% | +8.2% |
| Q3 2015 | $763,730,000 | +31.5% | 144,100 | +105.9% | 0.22% | +83.3% |
| Q2 2015 | $581,000,000 | – | 70,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |